| Profile | GDS4177 / 207966_s_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 616.79 | 92 |
| GSM603099 | KU-812 non-treated | 486.88 | 89 |
| GSM603098 | KCL-22 Imatinib-treated | 652.48 | 92 |
| GSM603097 | KCL-22 non-treated | 329.04 | 85 |
| GSM603102 | JURL-MK1 Imatinib-treated | 633.13 | 92 |
| GSM603101 | JURL-MK1 non-treated | 355.24 | 86 |